A 'power event' at Google Cloud just knocked UK banking apps offline
Revolut, Halifax, and Emma went dark Tuesday as Google's London cloud region failed. Here's what it means for fintech's reliance on Big Tech infrastructure.

Loading the Newsroom
Curating from trusted global sources…
271 briefings · “io”
Revolut, Halifax, and Emma went dark Tuesday as Google's London cloud region failed. Here's what it means for fintech's reliance on Big Tech infrastructure.
Brent's five-month high tightens supply, lifts diesel costs, and puts a second straight Fed rate hike back on the table for next week.
A single-zone failure at Google's London data center disrupted court hearings and left millions unable to pay or move money, exposing the fragility of cloud concentration.
Beijing's EV giants are shifting from exports to local assembly, spending billions to keep their European sales boom alive.
A final call from Beijing puts high-net-worth individuals on notice: declare offshore trust gains by October 22 or face penalties, with ripple effects for Hong Kong's wealth hub.
The U2 frontman reveals the band's pricing philosophy: affordable front rows, premium prices for the wealthy, as concert costs hit record highs and regulators circle Live Nation.
The dismissal clears the singer's bestselling memoir of defamation claims, a win for authors and publishers facing similar suits.
A second $45B deal would bring the pair's total to $90B and escalate the AI compute race.
A federal judge refused to release Abdulrahman Alfozan, citing flight risk and Saudi government support for his bond, deepening a national security case.
The chief international anchor who started as an assistant in 1983 is out, forcing CNN to rethink its global news identity.
A Russian military spacecraft closed from hundreds of kilometers to extreme proximity with a commercial satellite, signaling a new orbital threat to private assets.
The all-cash deal adds divesiran, a late-stage-ready rare-disease therapy, to Merck KGaA's pipeline and signals a new wave of RNA therapeutics M&A.